IDDF2024-ABS-0318 Ligusticum cycloprolactam (LIGc), a novel FXR agonist: target activation of FXR ameliorate metabolic associated fatty liver disease
Year: 2024
Type: conference-paper
Authors: Yongqi Yang, Xin Ding, Tian Lan
Institution: Harbin Medical University
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4401512630